Even Japan can't invest on this scale. "Chang says that it's no wonder many people are anticipating the creation of a biotech equivalent to chip foundry Taiwan Semiconductor. From the Taiwanese perspective, the biotech business model itself presents a potential problem. Biotech businesses manufacture one product for an extended period.
「這樣的投資，別說台灣，就連日本都還沒有，」張子文指出，無怪乎許多人期待「生技業的台積電」早日誕生。